Systems and methods are disclosed herein for switching an application executing on an ambulatory medical device to a new application without interrupting therapy provided by the ambulatory medical device to a subject. The ambulatory medical device may receive an indication that an update to an application executing on the ambulatory insulin pump is available, establish a communication connection to a host computing system, download and install the application update, while a prior version of the application continues to run. The disclosed systems and methods can confirm successful installation of the application update on the ambulatory medical device and switch control of the ambulatory medical device from the prior version to the new version of the application without interrupting therapy provided to the subject.

Systems and methods for human-machine interaction using a conversation system.

Systems and methods are provided for performing intraoperative fusion of two or more volumetric image datasets via surface-based image registration. The volumetric image datasets are separately registered with intraoperatively acquired surface data, thereby fusing the two volumetric image datasets into a common frame of reference while avoiding the need for complex and time-consuming preoperative volumetric-to-volumetric image registration and fusion. The resulting fused image data may be processed to generate one or more images for use during surgical navigation.

A user interface for clinical personnel provides selectable views of a plurality of medical risk scores. Questions whose answers are needed for calculation of those risk scores are asked in a question and answer area of the user interface, which allows some questions to be answered based on real time patient physiological data streams that are overridable by user provided answers. Where multiple risk score calculations require answers to the same question, the user provided answer may be supplied as an answer to the corresponding question for each risk score, rather than requiring the user to answer multiple times. Sparklines may be provided with the displayed risk scores to show trends in the risk score values, and may be updated in real time based on real time physiological data streams. The display of risk scores may visually distinguish between risk scores that have been validated and those are based on unvalidated answers to the questions.

A user interface for clinical personnel provides selectable views of a plurality of medical risk scores. Questions whose answers are needed for calculation of those risk scores are asked in a question and answer area of the user interface, which allows some questions to be answered based on real time patient physiological data streams that are overridable by user provided answers. Where multiple risk score calculations require answers to the same question, the user provided answer may be supplied as an answer to the corresponding question for each risk score, rather than requiring the user to answer multiple times. Sparklines may be provided with the displayed risk scores to show trends in the risk score values, and may be updated in real time based on real time physiological data streams. The display of risk scores may visually distinguish between risk scores that have been validated and those are based on unvalidated answers to the questions.

A method of providing personalized treatment for a diabetes patient including a remote device which is configured to receive a first data indicative of an analyte level of a subject during a first time period, retrieve a first glycated hemoglobin level for the subject associated with the first time period, calculate a first personal apparent glycation ratio for the first time period using the received first data and the retrieved first glycated hemoglobin level, compare the calculated first personal apparent glycation ratio to a representative apparent glycation ratio, generate a recommendation based on the comparison, and display a graphical interface comprising the calculated first personal apparent glycation ratio, the representative apparent glycation ratio, and the comparison.

An example system for therapy delivery includes one or more processors configured to in response to a prediction indicating that the meal event is to occur, output instructions to an insulin delivery device to deliver a partial therapy dosage, to a device to notify the patient to use the insulin delivery device to take the partial therapy dosage, or to the insulin delivery device to prepare the partial therapy dosage prior to the meal event occurring, and in response to a determination indicating that the meal event is occurring (e.g., based on movement characteristics of a patient arm), output instructions to the insulin delivery device to deliver a remaining therapy dosage, to the device to notify the patient to use the insulin delivery device to take the remaining therapy dosage, or to the insulin delivery device to prepare the remaining therapy dosage.

The invention comprises a method for estimating state of a cardiovascular system, comprising the steps of: providing a cardiac analyzer, comprising: a blood pressure sensor, the blood pressure sensor generating a time-varying pressure state waveform output from a portion of a person; a system processor connected to the blood pressure sensor; and a dynamic state-space model of a cardiovascular system, the system processor receiving cardiovascular input data, from the blood pressure sensor, related to a transient pressure state of the cardiovascular system, where at least one probabilistic model, of the dynamic state-space model, operating on the time-varying pressure state waveform output generates a probability distribution function to a non-pressure state of the cardiovascular system. The probability distribution function is iteratively updated using synchronized updated time-varying pressure state waveform output from the blood pressure sensor and a non-pressure state output related to a cardiovascular system parameter is generated.

A method for monitoring a flowrate of cerebrospinal fluid (CSF) in a ventriculo-peritoneal (VP) shunt implanted in a human patient includes: (i) receiving, at a device external to the human patient, data sensed by a plurality of sensors within the device and positioned relative to the VP shunt to drain excess cerebrospinal fluid from the human patient's brain; (2) determining, by the device and based on the sensed data, a rate of flow of the CSF in the VP shunt; and (3) transmitting (e.g., wirelessly), by the device, data indicating the rate of flow to a computing server.

A method for monitoring a flowrate of cerebrospinal fluid (CSF) in a ventriculo-peritoneal (VP) shunt implanted in a human patient includes: (i) receiving, at a device external to the human patient, data sensed by a plurality of sensors within the device and positioned relative to the VP shunt to drain excess cerebrospinal fluid from the human patient's brain; (2) determining, by the device and based on the sensed data, a rate of flow of the CSF in the VP shunt; and (3) transmitting (e.g., wirelessly), by the device, data indicating the rate of flow to a computing server.